Literature DB >> 10440159

Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms.

I D Cox1, H E Bøtker, J P Bagger, H S Sonne, B O Kristensen, J C Kaski.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the relationship between arterial and coronary sinus endothelin (ET) concentrations and coronary vasomotor responses during rapid atrial pacing in patients with chest pain and normal coronary arteriograms (CPNA).
BACKGROUND: Plasma ET concentrations are significantly higher in CPNA patients than in healthy control subjects.
METHODS: We investigated 19 carefully characterized CPNA patients (14 women; mean age 53 +/- 9 years) of whom 10 had positive electrocardiographic responses to exercise. The percentage fall in coronary vascular resistance (%d.CVR) after 10 min of rapid atrial pacing was determined using a thermodilution pacing catheter. Plasma ET concentrations were measured by radioimmunoassay on simultaneously drawn arterial and coronary sinus samples.
RESULTS: No significant differences in ET concentrations were observed between men and women, but a strong statistical trend suggested that %d.CVR was lower in women than men (27[23 to 31]% vs. 34[29 to 45]%--median[interquartile range]; p = 0.07). Simple regression analysis including only the women (n = 14) suggested a significant relationship between baseline arterial ET concentrations and %d.CVR (R2 = 0.34; p = 0.06). Furthermore, stepwise multivariate regression analysis of the group as a whole indicated that both gender (p = 0.03) and baseline arterial ET concentration (p = 0.02) were independently predictive of %d.CVR (R2 = 0.44; overall p = 0.02); this relationship predicts that women with high ET levels would have the lowest %d.CVR during pacing.
CONCLUSIONS: These data support the hypothesis that elevated ET activity may be associated with reduced coronary flow responses during rapid atrial pacing in CPNA patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440159     DOI: 10.1016/s0735-1097(99)00224-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

Review 1.  Cardiac syndrome X: a critical overview and future perspectives.

Authors:  G A Lanza
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

2.  Angina in Women without Obstructive Coronary Artery Disease.

Authors:  Kamakki Banks; Monica Lo; Amit Khera
Journal:  Curr Cardiol Rev       Date:  2010-02

Review 3.  Cardiac syndrome X and microvascular coronary dysfunction.

Authors:  Erika Jones; Wafia Eteiba; Noel Bairey Merz
Journal:  Trends Cardiovasc Med       Date:  2012-09-29       Impact factor: 6.677

Review 4.  Gender and microvascular angina.

Authors:  Lynn Nugent; Puja K Mehta; C Noel Bairey Merz
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

Review 5.  Cardiac syndrome X in women: the role of oestrogen deficiency.

Authors:  J C Kaski
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

Review 6.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

7.  Endothelin-1 impairs coronary arteriolar dilation: Role of p38 kinase-mediated superoxide production from NADPH oxidase.

Authors:  Naris Thengchaisri; Travis W Hein; Yi Ren; Lih Kuo
Journal:  J Mol Cell Cardiol       Date:  2015-07-23       Impact factor: 5.000

8.  Novel biomarkers of coronary microvascular disease.

Authors:  Olivia Y Hung; Suegene K Lee; Parham Eshtehardi; Habib Samady
Journal:  Future Cardiol       Date:  2016-06-13

Review 9.  Coronary microvascular dysfunction in women: an overview of diagnostic strategies.

Authors:  Sujith Kuruvilla; Christopher M Kramer
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-11

10.  Association between anxiety disorder and the extent of ischemia observed in cardiac syndrome X.

Authors:  I A C Vermeltfoort; P G H M Raijmakers; D A M Odekerken; A F M Kuijper; A Zwijnenburg; G J J Teule
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.